Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Family Medicine | Gynecology | Pharmacy | Institutional

Back to Journal Articles

Pfizer Recalling 28 Lots of Oral Contraceptives

Last Updated: February 01, 2012.

 

Packaging error may put women at risk for unintended pregnancy

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Pfizer Inc. announced yesterday that it is voluntarily recalling specific lots of oral contraceptives upon learning of a packaging error that may put women at risk for unintended pregnancy, according to a safety alert issued by the U.S. Food and Drug Administration.

WEDNESDAY, Feb. 1 (HealthDay News) -- Pfizer Inc. announced yesterday that it is voluntarily recalling specific lots of oral contraceptives upon learning of a packaging error that may put women at risk for unintended pregnancy, according to a safety alert issued by the U.S. Food and Drug Administration.

The subjects of the recall are 14 lots each of Lo/Ovral-28 (norgestrel and ethinyl estradiol) Tablets and Norgestrel and Ethinyl Estradiol Tablets (generic). An investigation on behalf of the manufacturer found that some blister packets may contain tablets with an inexact count of active or inert ingredients, and that tablets may be out of sequence.

The packaging defects do not pose immediate health risks, but could leave women without adequate contraceptive protection. Women who may have been exposed to faulty packaging are advised to start using a non-hormonal form of birth control immediately, and to notify their physician and return packets to their pharmacy.

"These products are packaged in blister packs containing 21 tablets of active ingredients and seven tablets of inert ingredients. Correct dosing of this product is important in avoiding the associated risks of an unplanned pregnancy," Pfizer said in a statement.

More Information

Copyright © 2012 HealthDay. All rights reserved.


Previous: ASCO: Radium-223 Promising for Prostate Cancer Bone Mets Next: AAP: Childhood Vaccination Schedules Approved for 2012

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.